Serial analysis of coronary artery disease progression by artificial intelligence assisted coronary computed tomography angiography: early clinical experience
Source check: Source checked. Not independent scientific confirmation.
Finding: AI-assisted CCTA quantification across serial scans measured coronary plaque progression in an early clinical series; the longitudinal imaging result is descriptive and the article calls for prospective outcome studies.
Technology: AI-assisted CCTA plaque-quantification method
Publication: Peer-reviewed paper · Test context: prospective or independent check. Catalog categories, not an evidence grade.
- AI contribution
- Quantifies coronary plaque features across serial CCTA scans to describe progression in an early clinical series.
- Test and result
- Validation or comparison reported in the source was checked and the conclusion is limited to that design and cohort; caveats noted in reason.
- Limitation / still unknown
- the longitudinal imaging result is descriptive and the article calls for prospective outcome studies.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://doi.org/10.1186/s12872-022-02951-9 · https://europepmc.org/article/MED/36435762 · https://europepmc.org/articles/PMC9701371 · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC9701371/unicode
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 4/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.